Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01810991 · ClinicalTrials.gov registry record · NA
Investigation of Hyperhidrosis Treatment Using the Nd: YAG 1440nm Wavelength Laser
A NA study, sponsored by Cynosure.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT01810991: Completed NA study, sponsored by Cynosure.
NCT01810991 is a NA study that has completed, run by Cynosure. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01810991, a NA study, has completed, sponsored by Cynosure.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of the Nd:YAG 1440 nm wavelength laser for the treatment of primary hyperhidrosis of the axilla.
Primary Outcome
3 trained blinded evaluators were asked to pick the post treatment photo from pre and post treatment photograph sets.
Interventions
- DEVICE Nd:YAG Laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2012-06 |
| Est. Completion | 2014-04 |
| Phase | NA |
What the finished NCT01810991 record still lists
NCT01810991 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Nd:YAG Laser is the first listed.
NCT01810991 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01810991 about?
NCT01810991 is a clinical study titled "Investigation of Hyperhidrosis Treatment Using the Nd: YAG 1440nm Wavelength Laser". The purpose of this study is to evaluate the safety and efficacy of the Nd:YAG 1440 nm wavelength laser for the treatment of primary hyperhidrosis of the axilla.
What is the current status of trial NCT01810991?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2012-06. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01810991?
The interventions under investigation include: Nd:YAG Laser (DEVICE).
Who is sponsoring clinical trial NCT01810991?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01810991's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia